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Abstract 
Alcohol addiction is a major psychiatric disease, and yet, the underlying molecular 
adaptations in the brain remain unclear. Recent evidence suggests a functional role 
for the ras-specific guanine-nucleotide releasing factor 2 (Rasgrf2) in alcoholism. 
Rasgrf2-/- (MT) mice consume less alcohol and show entirely absent dopamine 
responses to an alcohol challenge compared to wild types (WT). In order to further 
investigate how Rasgrf2 modifies the acute and subchronic effects of alcohol in the 
CNS, we investigated its effects on the noradrenergic (NA) and serotonergic (5-HT) 
systems. In-vivo microdialysis showed significantly reduced NA and 5-HT responses 
in the nucleus accumbens (NAcc) and caudate putamen (CPu) after an alcohol 
challenge in Rasgrf2-/- mice. A co-expression analysis showed that there is a high 
correlation between Rasgrf2 and α2 adrenoceptor RNA expression in the NAcc in 
naïve animals. Accordingly, we further assessed the role of Rasgrf2 in the 
neuroadaptations of the noradrenergic system following subchronic alcohol 
exposure. Rasgrf2-/- mice did not show the WT observed adaptation of β1 
adrenoceptor expression, but expressed β2 and α2 adrenoceptors at a reduced level. 
These findings suggest that adaptations in the noradrenergic system contribute to the 
Rasgrf2 enhanced risk of alcoholism.   
 
Key Words: Rasgrf2, alcohol, noradrenaline, serotonin, microdialysis, α2 
adrenoceptor  
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Introduction 
Alcohol addiction is a major psychiatric disease. The World Health Organisation 
(WHO) estimates that 4% of deaths worldwide each year are associated with the 
harmful use of alcohol (WHO 2011). Alcohol use develops into addiction in a 
significant number of people. While significant heritability estimates of alcohol 
addiction have been identified (Plomin 1990), underlying specific genetic influences 
are emerging slowly (Schumann et al. 2011; Stacey et al. 2009). In a recent study, 
we found evidence for a role of the ras-specific guanine-nucleotide releasing factor 2 
(RASGRF2) gene in alcoholism (Stacey et al. 2012). The study reported a genome 
wide association of RASGRF2 and alcohol consumption in 28,188 individuals. 
Rasgrf2 belongs to a family of calcium/calmodulin associated guanine 
nucleotide exchange factors (GEFs). Rasgrf2 activates the RAS protein which is 
known to stimulate the mitogen-activated protein kinase/ extracellular signal-
regulated kinase (MAPK/ERK) signal transduction pathway, by allowing the 
exchange of GDP for GTP, thereby regulating signalling pathways in cells. Although 
deletion of RASGRF2 has the potential to have a major impact on neuronal signalling 
pathways, knockout of RASGRF2 does not interfere with basal developmental in 
mice (Fernández-Medarde et al. 2002).  
Evidence suggests that Rasgrf2 acts on pathways which are also implicated in 
alcoholism. The RAS-MAPK/ERK pathway has been linked to dopamine D1 
receptors (Girault et al. 2007; Tian et al. 2004), and has also been isolated as a 
binding partner of the dopamine transporter (Maiya et al. 2007). These studies report 
a role for Rasgrf2 both pre- and post-synaptically. Bloch-Shilderman and colleagues 
(2001) reported a direct role for the MAPK/ERK pathway in neurotransmitter release. 
Rasgrf2, as a MAPK/ERK activating protein, may therefore be linked to 
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neurotransmitter release. Rasgrf2-/- (MT) mice were subsequently found to show 
entirely absent dopamine responses in the nucleus accumbens (NAcc) and caudate 
putamen (CPu) to an alcohol challenge. This may account for the reduced alcohol 
intake and alcohol preference of Rasgrf2-/- mice when compared to their wild-type 
(WT) litter mates (Stacey et al. 2012). In order to further investigate how Rasgrf2 
modifies the acute and subchronic effects of alcohol in the central nervous system 
(CNS), we investigated its control of the noradrenergic (NA) and serotonergic (5-HT) 
systems. These monoaminergic systems are consistently implicated in the 
modulation of alcohol’s effects on the reward system (Fahlke et al. 2011; Spanagel 
2009; Vengeliene et al. 2008). Next to DA, NA and 5-HT are important modulatory 
transmitters which are involved in the acute and subchronic behavioral effects of 
alcohol (Fahlke et al. 2011; McBride 2010) that contribute to behavioural changes 
associated with binge drinking and addiction (Smith et al. 2008).  
We performed in-vivo microdialysis measuring NA and 5-HT levels in the NAcc and 
CPu after an alcohol challenge in Rasgrf2-/- mice. We found that a Rasgrf2 deficiency 
significantly reduced NA and 5-HT responses in both brain regions. In order to 
assess the role of Rasgrf2 in the neuroadaptations to subchronic alcohol exposure, 
we measured mRNA expression of noradrenergic receptors and transporter in the 
brain and tested whether blood mRNA adaptations would be predictive for brain 
adaptations.   
 
 
 5 
Experimental Procedures 
 
All housing and experimental procedures were performed in accordance with the 
U.K. Home Office Animals (Experimental Procedures) Act 1986. All efforts were 
made to minimize animal suffering and to reduce the number of animals used. 
 
Animals 
Male wild type (+/+ WT) and null mutant (-/- MT) Rasgrf2tm1Esn (Fernández-Medarde 
et al. 2002) mice were studied. Mice were generated using a gene targeting strategy 
and subsequently kept on a genetic background of 129/S-J and C57BL/6. Detailed 
methods are described by Fernández-Medarde et al. (2002). The method inactivates 
the Grf2 locus by targeting its CDC25-H catalytic domain, thereby disrupting the 
guanine nucleotide exchange factor (GEF) activity of Rasgrf2. Animals were 
individually housed, provided with food and water ad libitum, and kept on a 12:12 
hour light: dark cycle (lights on at 7.00 am). Experiments were performed during the 
light cycle between 09:00 and 16:00 h, in a pseudorandom order. Room temperature 
was maintained between 19°C and 22°C at a humidity of 55% (±10%). Animals were 
housed in Tecniplast cages (32cm x 16cm x 14cm), using Litaspen sawdust and 
nesting materials, (Sizzlenest, Datsand, Manchester UK).  
 
Microdialysis surgery  
Mice (WT: n=7; MT: n=6) were deeply anaesthetised with an intraperitoneal (i.p.) 
injection using a mixture of 4.12ml saline (NaCl), 0.38ml Ketaset (containing 
100mg/ml Ketamine) and 0.5ml Domitor (containing 1mg/ml Medetomidine 
hydrochloride) administered at 0.1ml per 10g bogy weight. In addition 0.01ml 
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Rimadyl (5mg/Kg Carprofen) analgesia was given s.c. The animal was placed in a 
Kopf stereotaxic frame. Two guide cannulas (Microbiotech/se AB, Stockholm, 
Sweden) were aimed at the CPu (A: +0.5; L: ±2.3; V: -2.4 angle ±10º from midline) 
and the NAcc (A: +1.2; L: ±1.6; V: -4.3 angle ±10º from midline) using coordinates 
relative to bregma (Paxinos and Franlin 2003), and fixed in place using two anchor 
screws (stainless steel, d=1.4mm) and dental cement. Reverse anaesthesia was 
administered to the animals after approximately 45 minutes using a mixture of 3.9ml 
saline (NaCl) and 0.1ml Antisedan (containing 5mg/ml Atipamezole) at 0.08ml per 
10g body weight (s.c.). The animals were kept warm and allowed to recover from the 
anaesthetic. Animals were then returned to their home cages and monitored daily, 
allowing at least 5 days for complete recovery. 
 
Microdialysis procedure 
One week after implantation, microdialysis probes of a concentric design (membrane 
lengths: 2mm for the CPu (MAB 6.14.2.); 1mm for the NAcc (MAB 6.14.1)), were 
inserted into the guide cannulae under a short (3-5minute) Isoflurane anaesthesia 
(O2 at 1L/min, Isoflurane at 3% to induce and 2% to sustain). After probe insertion, 
the animal was placed into the open field (21x21x30cm) of a Truscan system 
(Coulbourn Instruments, Allentown, USA). Food and water were given ad libitum and 
room temperature maintained between 19 ºC and 22 ºC. The microdialysis probes 
were connected to a microinfusion pump (CMA 400, Carnegie, Sweden) via a swivel 
mounted on a balanced arm above the chamber, and were perfused with artificial 
cerebrospinal fluid (aCSF) (containing Na+ 147 mmol, K+ 4 mmol, Ca2+ 2.2 mmol, Cl- 
156 mmol, pH = 7.4) at room temperature (Müller and Huston 2006). The flow rate 
was set to 1.5μl/min and allowed to stabilise for at least two hours until a stable 
 7 
baseline was obtained. Samples were collected every 20 minutes into vials 
containing 2.73μl of antioxidant (0.1 M perchloric acid and 500 pg 
dihydroxybenzylamine (DHBA) as internal standard). Three samples taken during the 
first testing hour of the experiment provide baseline quantities of NA and 5-HT. An 
injection of alcohol was then administered at 2g/Kg, vinj= 10 ml/kg (i.p.). A further ten 
samples were collected simultaneously to behavioural data collection. 
 
HPLC-ED analysis 
All samples were analysed using High Performance Liquid Chromatography with 
Electrochemical Detection (HPLC-ED) to measure NA and 5-HT levels in the CPu 
and NAcc. The column used was an ET 125/2, Nucleosil 120-5, C-18 reversed phase 
column (Macherey–Nagel, Germany) perfused with a mobile phase composed of 75 
mM NaH2PO4, 4 mM KCl, 20μM ethylenediamine tetraacetic acid (EDTA), 1.5 mM 
sodium dodecyl sulfate, 100 μl/l diethylamine, 12% methanol, and 12% acetonitrile 
adjusted to pH 6.0 using phosphoric acid (Amato et al. 2011; Pum et al. 2008). The 
electrochemical detector (Intro, Antec, The Netherlands) was set at 500 mV vs an in 
situ Ag/AgCl (ISAAC) reference electrode (Antec, Leyden, Netherlands) at 30°C. The 
detection limit of the assay was 0.1pg with a signal–noise ratio of 2:1.  
 
Behavioural analysis 
Locomotor activity was measured simultaneously to in-vivo microdialysis 
experiments. Horizontal locomotor activity was automatically calculated by the 
Truscan system in 20 min intervals.  
 
Histological analysis 
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Once microdialysis experiments were complete, animals were sacrificed by cervical 
dislocation and the localization of microdialysis probes was verified. Only animals 
with probe placement within the CPu and the NAcc were considered for data 
analysis. 
 
Subchronic alcohol treatment 
In order to investigate the link between Rasgrf2 and the noradrenergic and 
serotonergic systems in the brain and the neuroadaptations following subchronic 
alcohol treatment, we tested mRNA expression in the brain and blood. Single housed 
Rasgrf2-/- (n=8-9/group) and WT mice (n=8-9/group) received a daily i.p. injection 
with either alcohol (3.5 g/kg) or saline for 7 days. After each injection animals were 
placed back to their home cages. 120 minutes after the last injection, animals were 
sacrificed by cervical dislocation and the brain and spleen were removed and 
immediately cooled on dry ice. Tissue was kept at -80 °C until further analysis.  
 
Tissue preparation  
The frozen brains were placed on a cold dissecting surface and hemispheres were 
separated by cutting in the sagittal plane. After removing the cerebellum and frontal 
cortex, the dorsal and ventral striatum and the hippocampus were dissected. Total 
RNA was extracted using a modified Qiagen-protocol: A phenol-extraction in Qiazol 
(Qiagen) was followed by column-purification with Rneasy Mini Kit (Qiagen), 
including DNase digestion according to manufacture’s protocol. cDNA was 
synthesized using iScript cDNA Synthesis Kit (Biorad, Munich/Germany) following 
manufacturer’s instructions.  
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RNA amplification and microarray hybridisation  
We generated biotinylated, amplified RNA from total RNA by using the Illumina® 
TotalPrep™ RNA Amplification kit (Applied Biosystems/Ambion, Austin, TX, USA) 
following the manufacturer’s instructions. Briefly, 500ng of total RNA was converted 
into first strand cDNA. After second strand cDNA synthesis and cDNA purification, in 
vitro transcription overnight generated biotinylated amplified RNA, which was purified 
and quantified using a Qubit® 2.0 Fluorometer (Invitrogen Ltd., Paisley, UK). The 
size distributions of amplified RNA were made by running each sample on the 
Bioanalyzer (Agilent Technologies UK Ltd., Wokingham, UK) using the Eukaryotic 
mRNA Assay with smear analysis.  
 
Gene expression profiling 
In order to investigate how expression of noradrenergic and serotonergic genes 
depends on Rasgrf2, we measured expression profiles in the NAcc of Rasgrf2-/- and 
WT mice after saline treatment. Gene expression profiling was performed using the 
Illumina Mouse WG-6 v2.0 Expression BeadChip that contains 45,281 probes 
(Illumina Inc., San Diego, CA, USA). 1.5µg of amplified RNA was used for 
hybridization of each array. The hybridization, washing and scanning were performed 
according to the manufacturer’s instructions.   
 
RT-PCR analysis 
Gene expression analysis in the NAcc showed a relationship of Rasgrf2 with α2 
adrenoceptor mRNA expression, but not with serotonergic gene expression. 
Accordingly, we focused the analysis of alcohol-induced brain-wide gene expression 
on noradrenergic genes only. Quantitative RT-PCR was performed using SYBR 
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Green I Master Mix buffer (Applied Biosystems), and reactions were run on an 
iCycler (Roche) using a three-step standard protocol. The annealing temperature 
was optimized for all primer pairs and ranged from 55 to 65 °C. PCR products were 
visualized on standard 2% agarose gels with ethidium bromide to eliminate the 
possibility of having amplified genomic DNA. β-Actin was used as internal standard, 
and CT values were calculated from differences between β-actin and the target 
genes. All experiments were repeated at least three times and the mean value used 
for further analysis. 
The following primer pairs were used: 
Β-Actin-F: CTGTATTCCCCTCCATCGTG 
Β-Actin-R: GAAGATCTGGCACCACACCT 
NAT-F: TCAACTTCAAGCCGCTTACC 
NAT-R: GGTTCAGATAGCCAGCCAGT 
Adra2a-F: GTTCTGGCTGAGAGGG 
Adra2a-R: AAGGAAGGGGGTGTGGAG 
Adra2b-F: GCAGAGGTCTCGGAGCTAA  
Adra2b-R: GCCTCTCCGACAGAAGATA 
Adra1b-F: GAAAAGAAAGCAGCCAAA 
Adra1b-R: CTGGAGCACGGGTAGATGAT 
 
 
Statistical Analysis 
Behavior and neurochemistry: All graphical output data were expressed as a mean ± 
SEM. Baseline behavioural and neurochemical data were analysed using pre-
planned t-test comparisons to determine the differences seen between genotype 
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groups prior to alcohol administration. To compare the effect size of alcohol affected 
by genotype, the area under the curve (AUC) was established for locomotor 
activation. Data was analysed using planned t-test comparisons. Alcohol induced 
neurochemical data was expressed as a percentage of the mean of the three 
baseline samples which were taken as 100%. Data were compared using two-way 
ANOVAs for factor genotype (3) and time (13). To compare alcohol effects of certain 
time points, pre-planned Bonferroni-corrected t-test comparisons were performed 
versus average baseline value.  
Gene expression: The mRNA expression was calculated as deltaCT (mean+SEM). 
For statistical analysis, two-way ANOVAs with factors genotype and treatment were 
used. To evaluate genotype effects on single brain area and blood level, pre-planned 
comparisons using Bonferroni-corrected Fisher’s LSD test were calculated. A 
correlation analysis of brain and blood mRNA expression (Pearson correlation) was 
performed for all target mRNA with pooled genotypes. The software used was 
Statistica 7.0. A significance level of p<0.05 was used to test for statistical 
significance.  
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Results 
 
Rasgrf2 deficiency is associated with increased locomotion and basal 
noradrenaline activity 
Basal activity of Rasgrf2-/- and WT mice was significantly different (Fig.1A). Rasgrf2-/- 
mice were found to have a higher level of locomotor activity than WT mice (t=2.71, 
df=34, p=0.01). Rasgrf2-/- mice were also found to have increased basal NA levels in 
the NAcc (t=4.32, df=37, p<0.001) and the CPu (t= 5.56, df=37, p<0.0001), 
compared to WT mice (Fig. 2A). Rasgrf2-/- mice showed enhanced basal 5-HT levels 
in the NAcc (t=-4.87, df=37, p<0.0001) but decreased levels the CPu (t= 3.78, df=38, 
p<0.0006), compared to WT mice (Fig. 3A). 
 
Rasgrf2 contributes to noradrenergic and serotonergic activation and 
behavioral activity after acute alcohol treatment 
Rasgrf2 WT mice showed a tendency towards an increased level of locomotor 
activation after an acute alcohol injection compared to Rasgrf2-/- mice (t=-2.06, df=10, 
p=0.06; Fig 1B).  
Noradrenaline levels in the NAcc steadily increased after an alcohol challenge (Fig. 
2B). Analysis showed a significant time effect (F12,120=7.38, p<0.001), but no 
genotype, or genotype x time interaction (p>0.05). A within group analysis using pre-
planned pairwise comparisons suggested that, compared to basal levels, WT mice 
show a significantly increased level of noradrenaline at 100 min (p<0.03), 120 min 
(p=0.05) and 200 min (p=0.05) after an acute injection of alcohol. Rasgrf2-/- mice 
show no significant differences in NA levels after the same alcohol treatment 
(p>0.05). 
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The NA response to alcohol in the CPu shows a similar reactivity to that seen in the 
NAcc. Two-way ANOVA revealed a significant time effect (F12,120=5.03, p<0.001; Fig. 
2C) effect, but no genotype effect or genotype x time interaction (p>0.05). Within 
group analysis confirmed significantly increased NA levels in the WT mice at 100 min 
(p=0.01), 120 min (p<0.001), after acute alcohol administration. Rasgrf2-/- did not 
significantly differ from basal transmitter levels after the same treatment (p>0.05). 
Alcohol treatment increased extracellular 5-HT levels in the NAcc of WT mice, but 
had no effect in Rasgrf2-/- mice (Fig. 3B). Analysis showed a significant effect of 
genotype (F1,9=17.41, p=0.002), and time (F12,108=2.02, p=0.03), but no genotype x 
time interaction (p>0.05). A within group analysis using pre-planned pairwise 
comparisons suggested that, compared to basal levels, WT mice show a significantly 
increased 5-HT level 20 min (p=0.03) after an acute alcohol injection. Rasgrf2-/- did 
not significantly differ from basal 5-HT levels in the Nacc after the same treatment 
(p>0.05). A similar 5-HT response was observed in the CPu. Alcohol treatment 
increased extracellular 5-HT levels in WT, but not in Rasgrf2-/- mice (Fig. 3C). 
Analysis showed a significant genotype effect (F1,10=11.81, p=0.006), but no time 
effect (p>0.05). However, there was a significant genotype x time interaction 
(F12,120=1.91, p=0.04). A within group analysis using pre-planned pairwise 
comparisons suggested that, compared to basal levels, WT mice showed a 
significantly increased 5-HT level 20 min (p=0.02), 60 min (p=0.05) and 120 min 
(p=0.02) after an acute injection of alcohol. Rasgrf2-/- did not significantly differ from 
basal 5-HT levels in the CPu after the same treatment (p>0.05). 
 
Rasgrf2 and α2 adrenoceptor co-expression in the ventral striatum   
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A co-expression analysis showed that there was a high correlation between Rasgrf2 
and α2 adrenoceptor (Adr2a) mRNA expression in the ventral striatum in WT animals 
(R=0.9277, p=0.0125). No other correlation of Rasgrf2 with noradrenergic or 
serotonergic gene expression reached significance (Suppl. Tab. 1 and 2). These 
findings suggest a link between Rasgrf2 and noradrenergic, but not serotonergic 
systems at the level of the ventral striatum.  
  
Rasgrf2 controls noradrenergic gene expression in the brain after alcohol 
treatment 
In order to further explore the role of Rasgrf2 in the establishment of alcoholism, we 
investigated the expression of noradrenergic genes in response to alcohol in Rasgrf2-
/- and WT mice. 
  
β1-adrenoceptor: There was no difference in β1-adrenoceptor mRNA between 
Rasgrf2-/- and WT after saline treatment (Fig. 2; ANOVA; genotype: F1,166=47.37, 
p<0.0001; treatment: F1,166=20.72, p=0.001; interaction: F1,166=24.67, p<0.0001). 
Subchronic alcohol treatment reduced mRNA expression significantly in the WT 
(p<0.0001), but not in the Rasgrf2-/- mice (p>0.05). Pre-planned comparisons showed 
a significant difference between Rasgrf2-/- and WT after alcohol (p<0.001), but not 
after saline treatment (p>0.05).  This difference was found in each brain area tested 
after alcohol treatment (frontal cortex: p=0.036; ventral striatum: p=0.012; dorsal 
striatum: p=0.008; hippocampus: 0.014; cerebellum: p=0.0008).    
 
β2-adrenoceptor: There was no difference in β2-adrenoceptor mRNA expression 
between Rasgrf2-/- and WT mice after saline treatment (Fig. 2; ANOVA; genotype: 
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F1,166=30.53, p<0.0001; treatment: F1,166=13.90; p=0.0003; interaction: F1,166=7.09, 
p=0.006). Subchronic alcohol treatment had no effect on β2-adrenoceptor mRNA 
expression in the WT (p>0.05), but reduced mRNA expression in the Rasgrf2-/- mice 
(p<0.0001). Pre-planned comparisons showed a significant difference between 
Rasgrf2-/- and WT after alcohol (p<0.0001), but not after saline treatment (p>0.05). 
This effect was found at single brain area level in the ventral striatum (p=0.003), 
hippocampus (p=0.022), and cerebellum: p<0.0001), but not in the frontal cortex 
(p>0.05), and only as a tendency in the dorsal striatum (p=0.08).    
 
α2-adrenoceptor: There was no significant difference in α2-adrenoceptor mRNA 
expression between Rasgrf2-/- and WT mice after saline treatment (Fig. 2). 
Subchronic alcohol treatment reduced mRNA expression significantly in the Rasgrf2-/-
, but not in the WT mice (ANOVA; genotype: F1,166=47.37, p<0.0001; treatment: 
F1,166=20.72, p=0.001; interaction: F1,166=24.67, p<0.0001). Pre-planned comparisons 
showed a significant difference between Rasgrf2-/- and WT mice after alcohol 
(p<0.0001), but not after saline treatment (p>0.05). The effect of Rasgrf2 was visible 
in all brain areas investigated after the alcohol treatment (frontal cortex: p=0.0004; 
ventral striatum: p=0.0013; dorsal striatum: p=0.011; hippocampus: p=0.0006; 
cerebellum: p=0.0002).    
 
Noradrenaline transporter: NAT mRNA expression did not differ between Rasgrf2-/- 
and WT mice, neither after saline nor after subchronic alcohol administration 
(ANOVA; genotype: F1,166=0.014, p=0.90; treatment: F1,166=2.38, p=0.12; interaction: 
F1,166=1.60, p=0.21). Pre-planned comparisons at single brain area level showed no 
difference in all brain areas tested (p>0.05).  
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Blood mRNA expression of noradrenergic genes and brain neuroadaptations to 
subchronic alcohol 
In order to test whether mRNA expression in peripheral blood could predict 
genotype- and/or alcohol-induced expression differences in the brain, we measured 
the expression of α2-, β1-, β2- and NAT mRNA in blood cells. There was no 
difference between genotypes in mRNA expression of all targets after saline 
treatment (p>0.05, Fig. 5). Visual inspection of the data suggested an alcohol-
induced decrease in β1 expression in WT animals, and a decrease of α2- and β2 
expression in Rasgrf2-/- animals. These effects, however, did not reach statistical 
significance (p>0.05). A correlation analysis for single brain areas, suggest that blood 
mRNA expression may predict β1 expression in the dorsal striatum and β2 
expression in the ventral striatum after saline treatment in WT animals. It may also 
predict NAT mRNA expression after alcohol in the WT animals in the frontal cortex. 
However, for the other investigated brain areas and treatment conditions there was 
no significant correlation between blood and brain mRNA expression (p>0.05; Tab. 
1). These findings suggest the use of blood mRNA as a marker for selective brain 
area expression of β1 and β2 adrenoceptor mRNA under basal conditions, and NAT 
adaptations in the frontal cortex after sub-chronic alcohol treatment.    
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Discussion 
 
The monoaminergic systems have consistently been implicated in the modulation of 
alcohols effects in the reward system (Fahlke et al. 2011; Spanagel 2009; 
Vengeliene et al. 2008). Noradrenaline and serotonin are involved in the modulation 
of alcohol’s behavioural and neurochemical effects (Fahlke et al. 2011; McBride 
2010). Both systems have been implicated in long term adaptive changes induced by 
alcohol consumption (Berggren et al. 2002; Fahlke et al. 1999; Nutt and Glue 1988). 
Rasgrf2 has recently been shown to mediate the dopaminergic responses to alcohol 
in the NAcc and CPu by controlling sensitivity of dopaminergic neurons in the ventral 
tegmental area (Stacey et al. 2012). The aim of the current study was to further 
characterize how Rasgrf2 contributes to acute and subchronic alcohol effects in the 
noradrenergic and serotonergic systems of the CNS. In this study, WT animals 
showed an alcohol-induced increase of extracellular NA and 5-HT levels in both the 
NAcc and the CPu. A corresponding increase in locomotor activity was also 
apparent. Mice lacking Rasgrf2 showed an enhanced baseline locomotor activity and 
enhanced NA levels in the NAcc and CPu. Serotonin levels were enhanced in the 
NAcc, but attenuated in the CPu. These findings suggest that a lack of Rasgrf2 
leaves mice in a hyperarousal state. Interestingly, an alcohol challenge induced less 
locomotor activation and NA responses in the Rasgrf2-/- mice compared to WT. The 
5-HT response, in addition, was completely lacking in Rasgrf2-/- mice. These findings 
may suggest that the locomotor stimulating effects of a medium dose of alcohol 
depend on Rasgrf2 integrity and on downstream NA and 5-HT activation. Given that 
basal locomotion and monoamine levels were already enhanced during baseline, the 
lack of an additional activation may be due to a ceiling effect in systems activity. 
Present data also suggest that Rasgrf2 controls basal NA and 5-HT activity. These 
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findings are largely in line with previously reported role of Rasgrf2 in the control of 
basal and alcohol-induced dopaminergic activity (Stacey et al. 2012).  
An analysis of mRNA co-expression of Rasgrf2 and important components of the 
noradrenergic and serotonergic systems showed that in the ventral striatum only the 
α2 adrenoceptor mRNA expression correlated highly with Rasgrf2. This suggests a 
strong link between Rasgrf2 and the NA system in an alcohol-reinforcement related 
brain area. Subsequent analysis, which sought to compare expression between 
different brain areas, focused on noradrenergic receptors and the NAT. After 
subchronic alcohol treatment, β1 adrenoceptor levels were elevated in WT mice in all 
brain areas tested, but there were no changes in β2 and α2 adrenoceptor levels, or in 
expression levels of NAT. Rasgrf2-/- mice after subchronic alcohol showed no 
adaptation of β1 adrenoceptors, but did differentially express β2 adrenoceptors in the 
ventral striatum, hippocampus and cerebellum, and α2 adrenoceptors in all brain 
areas tested at a reduced level. Like WT mice, Rasgrf2-/- mice showed no change in 
NAT expression. For both, Rasgrf2-/- and WT mice, blood levels showed a tendency 
towards the effects seen in brain tissue, but the findings could not be statistically 
verified. Although partial correlations between blood and brain tissue were obtained, 
they rather applied for saline treated animals and did not predict alcohol-induced 
adaptations.  
Present data suggest that Rasgrf2 regulates the adaptation of adrenoceptors to 
subchronic alcohol administration. Rasgrf2 appears to be essential for β1 adaptation, 
whilst normally preventing β2 and α2 adaptations. It appears that, only if Rasgrf2 is 
absent, can the adrenoceptor system adapt and possibly make the animal less 
vulnerable to alcohols rewarding effects. This would account for the diminished 
alcohol preference seen in the Rasgrf2-/- mice (Stacey et al. 2012). Increases in NA 
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have been shown to result in the down regulation of the β1 adrenoceptor in cardiac 
tissue (Dong et al. 1999; Thomas and Marks 1978). This may account for the WT 
adaptations we have observed in response to subchronic alcohol exposure. Since 
the Rasgrf2-/- NA response is reduced acutely, this may explain the absence of β1 
adaptation in these mice. In response to repeated alcohol treatments, WT mice do 
not typically alter their β2 and α2 adrenoceptor levels. However, Rasgrf2-/- mice show 
a distinct down regulation of these receptors. NA signalling through the α2 
adrenoceptor is known to be involved in the negative feedback control mechanism in 
neuronal synapses, thus, regulating NA release from the presynaptic nerve terminals 
of the CNS (Schwartz 1997; Starke 2001). Present data suggest that Rasgrf2 is 
capable of controlling the amount of NA released to the synaptic cleft. Rasgrf2 
activates the Ras protein and thereby stimulates the MAPK/ERK signaling pathway. 
Adrenoceptors have been shown to differentially alter the activation of the 
MAPK/ERK pathway (Williams et al. 1998). Williams and colleagues demonstrated 
that stimulation of the β1 adrenoceptors results in ERK activation, while stimulation of 
α2 adrenoceptors does not. Although this contravenes earlier studies, suggesting 
that α2 adrenoceptors also activate the MAPK/ERK pathway (Alblas et al. 1993; 
Howe and Marshall 1993; Winitz et al. 1993), the present study suggests Rasgrf2 
may play a role in this process. 
Since microdialysis was performed after acute treatment only, we cannot rule out the 
possibility of chronic adaptations of the neurochemical response (Berggren et al. 
2002), which may result from changes in adrenoceptor expression levels. In addition 
to this, not all adrenoceptors were measured in the present study, thus, one cannot 
say to what extent they might play a role in the NA response to subchronic alcohol 
exposure. Nor do our results rule out NAT expression changes in general, but only in 
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target area neurons. For example, there is a chance that NAT expression might be   
affected in the locus coeruleus neurons by Rasgrf2 (Zippel et al. 1997). 
 
Altogether, the current study reveals an important role of Rasgrf2 in the 
noradrenergic system’s response to alcohol. Rasgrf2 appears to mediate the 
presence of NA and 5-HT in the synaptic cleft at both, basal level and after acute 
alcohol stimulation. Rasgrf2 and the NA system are specifically linked by co-
expression of Rasgrf2 with α2 adrenoceptor mRNA at basal conditions. After 
repeated alcohol exposure, the NA system is modified, and Rasgrf2 regulates 
alterations in expression levels of adrenoceptor mRNA. Expression levels in 
blood/spleen samples may serve only with a very restricted focus as a predictor for 
noradrenergic adaptations in the brain after subchronic alcohol exposure. A lack of 
Rasgrf2 results in the failure of the noradrenergic system to adapt in the normal way 
to subchronic alcohol, which coincides with animals being less vulnerable to the 
incentive effects of alcohol.  
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Figure Legends: 
 
Figure 1: The role of Rasgrf2 in acute alcohol effects on locomotor activity. (A). 
Baseline locomotor activity and (B). Alcohol (2 g/kg, i.p.) induced locomotor 
activation as area under the curve (AUC) for 200 min after injection (**p<0.01, t-test).  
 
Figure 2: The role of Rasgrf2 in alcohol effects on noradrenaline activity. (A). 
Noradrenaline basal levels in the nucleus accumbens (NAcc) and caudate putamen 
(CPu) prior to alcohol treatment (***p<0.001, t-test). (B). Extracellular noradrenaline 
levels after acute alcohol (2 g/kg, i.p.) treatment in the NAcc and (C). In the CPu 
(*p<0.05,  **p<0.01,  ***p<0.001 vs. baseline). 
 
Figure 3: The role of Rasgrf2 in alcohol effects on serotonin activity. (A). Serotonin 
basal levels in the nucleus accumbens (NAcc) and caudate putamen (CPu) prior to 
alcohol treatment (***p<0.001, t-test). (B). Extracellular serotonin levels after acute 
alcohol (2 g/kg, i.p.) treatment in the NAcc and (C). In the CPu (*p<0.05 vs. baseline). 
 
Figure 4: The role of Rasgrf2 in alcohol-induced changes in mRNA expression of (A. 
and B.) β1-adrenoceptor, (C. and D.) β2-adrenoceptor, (E. and F.) α2-adrenoceptor, 
and (G. and H.) the noradrenaline transporter (NAT) in the brain of Rasgrf2-/- and wild 
type mice. Higher deltaCT values represent lower mRNA expression rate (mean ± 
SEM; FC - frontal cortex, VStr - ventral striatum, DStr - dorsal striatum, Hipp – 
hippocampus, Cerr – cerebellum; * p<0.05,**p<0.01, ***p<0.001).  
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Figure 5: The role of Rasgrf2 in alcohol-induced changes in mRNA expression of (A. 
and B.) β1-adrenoceptor, (C. and D.) β2-adrenoceptor, (E. and F.) α2-adrenoceptor, 
and (G. and H.) the noradrenaline transporter (NAT) in the blood of Rasgrf2-/- and 
wild type mice (mean ± SEM). Higher deltaCT values represent lower mRNA 
expression rate. 
 
 
Table 1: The correlation between blood and brain area mRNA expression in saline 
and alcohol treated Rasgrf2-/- (MT) and wild type (WT) mice (*p<0.05). 
 
 
 
 
 
 
 
